Gesponsert
Understanding the SCLC Drug Development Pathway: State of the Art and Beyond
  Small Cell Lung Cancer continues to challenge oncologists worldwide as one of the most aggressive and treatment-resistant malignancies. Despite demonstrating initial responsiveness to conventional chemotherapy and radiation protocols, patients inevitably experience disease recurrence, leading to survival rates considerably lower than other lung cancer types. This daunting clinical...
0 Kommentare 0 Geteilt 231 Ansichten 0 Bewertungen
Gesponsert
Gesponsert
Gesponsert